Psychiatrist - Bryker Woods (Greenbrook)

Neuronetics, Inc.; Austin (TX); On-site; USD 96,000 - 165,000; Part time

Benefits offered by this job

Flexible scheduling

Additional income opportunity

Specialized TMS certification and training

Job summary

A mental healthcare company is seeking part-time, board certified or board eligible psychiatrists for on-site TMS treatment and to expand the Spravato® program in Bryker Woods, TX. This role offers the opportunity to make a difference in patients' lives while enjoying flexibility with scheduling. The ideal candidates will have a commitment to mental health care and a desire to work in an innovative treatment environment. Competitive pay and additional training will be provided.

Qualifications

• Board certified or board eligible psychiatrists are required.
• Authorized to work in the U.S. without visa sponsorship.

Responsibilities

• Provide on-site TMS treatment for patients.
• Expand the Spravato® program in Bryker Woods, TX.
• Maintain compliance with employment terms and regulatory guidelines.

Skills

Board certification in psychiatry

Experience in TMS treatment

Flexibility in scheduling

Job description

Greenbrook TMS NeuroHealth Texas PLLC (a division of Greenbrook TMS NeuroHealth Centers Services, LLC)

IS SEEKING PART-TIME (1099) BOARD CERTIFIED & BOARD ELIGIBLE PSYCHIATRISTS FOR ON SITE TMS TREATMENT AND TO EXPAND SPRAVATO® PROGRAM IN BRYKER WOODS, TX.

Greenbrook now operates 95+ centers throughout the United States with a focus on specialized services for treatment-resistant depression, OCD, and other mental health disorders.

WHY JOIN?

• Expand your professional knowledge & clinical skillset
• Make a difference in the lives of patients using innovative treatment options
• Enjoy flexibility with respect to scheduling (no nighttime, weekend, or on-call hours) and hours worked per week
• Benefit from an additional income opportunity with competitive pay
• Receive specialized TMS certification and training
• Work alongside our experienced management & clinical leadership team

Who We Are

At the forefront of mental health care, Greenbrook operates 95+ U.S. centers offering cutting-edge, FDA-cleared TMS (targeted electromagnetic stimulation for mood regulation) and Spravato® (for treatment-resistant depression and MDD with suicidal thoughts/actions). This innovative approach has already touched the lives of over 40,000 patients, with more than 1.3 million treatments administered. To learn our WHY click here | Patient stories on HOW we transform lives click here | To access provider information, click here

• Applicants must be authorized to work for any employer in the US. We are unable to sponsor or assume responsibility for employment visa/work authorization at this time.

Greenbrook, a subsidiary of Neuronetics, is an equal opportunity employer that is committed to diversity and inclusion in the workplace. We prohibit discrimination and harassment of any kind based on race, color, sex, religion, sexual orientation, national origin, disability, genetic information, pregnancy or any other protected characteristic as outlined by federal, state, or local laws. This policy applies to all employment practices within our organization, including hiring, recruiting, promotion, termination, layoff, recall, leave of absence, compensation, benefits, training, and apprenticeship. Greenbrook makes hiring decisions based solely on qualifications, merit, and/or business needs at the time.

We are committed to providing equal employment opportunities to individuals with disabilities and protected veterans.

GBSP25

About Us

Neuronetics, Inc. is a leading mental healthcare company, now encompassing Greenbrook TMS as a subsidiary. This strategic acquisition unites Neuronetics' innovative NeuroStar® Advanced Therapy (TMS) technology with Greenbrook's extensive network of over 95 U.S. treatment centers. The combined company provides FDA-cleared NeuroStar® TMS and Spravato® treatments for major depressive disorder (MDD) and treatment-resistant depression. With a strengthened nationwide footprint, Neuronetics is dedicated to significantly expanding patient access to these crucial therapies, integrating advanced technology with established clinical expertise to improve patient outcomes and drive growth within the mental health sector.